Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H36O4 |
Molecular Weight | 364.5188 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C\C(C[C@@]1(C)C[C@@H](O)[C@@H]2\C=C\[C@@H](O)CCCCC)=C\CCCC(O)=O
InChI
InChIKey=VKPYUUBEDXIQIB-QBPWRKFFSA-N
InChI=1S/C22H36O4/c1-3-4-5-9-17(23)11-12-18-19-13-16(8-6-7-10-21(25)26)14-22(19,2)15-20(18)24/h8,11-12,17-20,23-24H,3-7,9-10,13-15H2,1-2H3,(H,25,26)/b12-11+,16-8-/t17-,18+,19+,20+,22-/m0/s1
Molecular Formula | C22H36O4 |
Molecular Weight | 364.5188 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 2 |
Optical Activity | UNSPECIFIED |
Ciprostene is a synthetic, chemically stable analog of prostacyclin (PGI2). In animal models, administration of ciprostene resulted in dose-dependent hypotension, tachycardia, and inhibition of ex vivo ADP-induced platelet aggregation. Ciprostene was evaluated in clinical trials in patients with peripheral vascular disease. It was found to reduce restenosis in patients with coronary artery disease undergoing therapeutic percutaneous transluminal coronary angioplasty.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:09:18 GMT 2023
by
admin
on
Fri Dec 15 16:09:18 GMT 2023
|
Record UNII |
KZ075BHY4P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C78568
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C79570
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110886
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
KZ075BHY4P
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
5513
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
6438980
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
81845-44-5
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
100000081523
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
DTXSID901024660
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
C045329
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
SUB07475MIG
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|